Skip to main content
. 2011 Dec 16;1(1):5. doi: 10.1007/s13554-011-0004-8

Table 5.

Incidence of adverse drug reactions during the first 18 months of treatment in all three studies.

Baseline-9 months 9–18 months Odds ratio
n % n %
AQ study* (n=44) 19 43.2 16 36.4 0.84
Lyo study (n=50) 12 24.0 10 20.0 0.83
Spanish study (n=69) 5 7.2 3 4.3 0.60

*Group B of AQ study.